Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Orca Bio

Orca Bio Announces Leadership Updates
From Orca Bio
Via Business Wire
Orca Bio Announces Positive Results from the Pivotal Phase 3 Study of Investigational Orca-T® Compared to Allogeneic Stem Cell Transplant for the Treatment of Hematologic Malignancies
From Orca Bio
Via Business Wire
Orca Bio’s Orca-T® Meets Primary Endpoint in the Pivotal Precision-T Phase 3 Clinical Study for Hematologic Malignancies
From Orca Bio
Via Business Wire
Orca Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Orca Bio
Via Business Wire
Orca Bio Presents Three-Year Survival Data with Orca-T® in Patients with Hematological Malignancies at the 66th ASH Annual Meeting
From Orca Bio
Via Business Wire
Orca Bio Presents Clinical Results on Use of Orca-Q® without GvHD Prophylaxis in Patients with Hematological Malignancies at the 66th ASH Annual Meeting
From Orca Bio
Via Business Wire
Orca Bio to Present Clinical Data on Its High-Precision Cell Therapies at the 66th American Society of Hematology Annual Meeting
From Orca Bio
Via Business Wire
Orca Bio Announces Completion of Patient Enrollment for the Precision-T Phase 3 Study of Orca-T
From Orca Bio
Via Business Wire
Orca Bio to Present Positive Clinical Outcomes with Orca-T in Patients with AML at 2024 ASCO Annual Meeting
From Orca Bio
Via Business Wire
Orca Bio to Present Positive Clinical Data on Orca-T at the 50th Annual Meeting of the EBMT
From Orca Bio
Via Business Wire
Orca Bio Presents Promising Data on Orca-T in Two Oral Presentations at the 2024 Tandem Meetings of ASTCT® and CIBMTR®
From Orca Bio
Via Business Wire
Orca Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Orca Bio
Via Business Wire
Orca Bio Presents Positive Data Demonstrating the Potential for Orca-T and Orca-Q to Expand Treatment to Additional Patient Groups at the 65th ASH Annual Meeting
From Orca Bio
Via Business Wire
Orca Bio to Present Positive Clinical Data on its Novel High-Precision Cell Therapies at the 65th American Society of Hematology Annual Meeting
From Orca Bio
Via Business Wire
Orca Bio Presents Positive Data Reinforcing Clinical Profile of Orca-T and Orca-Q at 2023 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR
From Orca Bio
Via Business Wire
Orca Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Orca Bio
Via Business Wire
Orca Bio Presents Encouraging Interim Clinical Data on Orca-Q in Haploidentical Allogeneic Hematopoietic Stem Cell Transplants at 64th ASH Annual Meeting
From Orca Bio
Via Business Wire
Orca Bio Presents Data Demonstrating its Lead Investigational High-Precision Cell Therapy Orca-T Significantly Improved Relapse-Free Survival at 64th ASH Annual Meeting
From Orca Bio
Via Business Wire
Orca Bio to Present Four Abstracts at the 64th American Society of Hematology Annual Meeting, Including Updated Relapse-Free Survival Data with Orca-T and the First Clinical Data for Orca-Q
From Orca Bio
Via Business Wire
Orca Bio Expands Manufacturing Capabilities to Develop and Commercialize its Precision Cell Therapies
From Orca Bio
Via Business Wire
Orca Bio Announces the Precision-T Phase 3 Study is Open and Enrolling Patients at Transplant Centers Across the U.S.
From Orca Bio
Via Business Wire
Orca Bio to Present New Clinical Data on Orca-T at the European Hematology Association 2022 Congress
From Orca Bio
Via Business Wire
Orca Bio Presents Positive Data Reinforcing Clinical Profile and Manufacturing Reliability of Orca-T at 2022 Transplantation & Cellular Therapy ASTCT and CIBMTR Tandem Meetings
From Orca Bio
Via Business Wire
Orca Bio to Present at the 40th Annual J.P. Morgan Healthcare Conference
From Orca Bio
Via Business Wire
Positive Clinical Results from More than 100 Patients Treated with Orca Bio’s Lead Investigational High Precision Cell Therapy Presented at 63rd ASH Annual Meeting
From Orca Bio
Via Business Wire
Orca Bio to Present New Clinical Data on Orca-T at the 63rd American Society of Hematology Annual Meeting
From Orca Bio
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.